Lovastatin
Product Images NDC 10544-242

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 10544-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 10mg 90ct (Label Lovastatin Tabs 10mg Bpi(10544 235 90) Carlsbad(61442 141 10) Rev1)

Lovastatin Tablets, USP 10 mg label for 90 tablets by Blenheim Pharmacal, Inc. The label includes NDC 10544-235-90, manufacturing code 61442-141-10, and storage instructions to keep at 20°-25°C (68°-77°F) in a tight, light-resistant container. It is marked Rx Only with directions to see package insert.*

FDA Label Image

Label 20mg 30ct (Label Lovastatin Tabs 20mg Bpi(10544 241 30) Carlsbad(61442 142 10) Rev2)

Lovastatin Tablets, USP 20 mg bottle label by Blenheim Pharmacal, Inc. The label states the strength as 20 mg with 30 tablets per bottle. It includes storage instructions, product identification details, and barcode information. The label also notes Rx only and directs to see the package insert for dosage.*

FDA Label Image

Label 40mg 30ct (Label Lovastatin Tabs 40mg Bpi(10544 242 30) Carlsbad(61442 143 10) Rev2)

Label for Lovastatin Tablets USP 40mg, containing 30 tablets. The label includes the NDC 10544-242-30, manufacturer code 61442-143-10, and states the product is Rx Only. It provides storage instructions to keep the tablets at 20°-25°C (68°-77°F) in a light-resistant container and out of reach of children. The label shows the manufacturer as Blenheim Pharmacal, Inc.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure of Lovastatin, showing its molecular arrangement with multiple rings and functional groups, including hydroxyl and keto groups.*

FDA Label Image

Table I (Lov00 0004 02)

A data table titled 'The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered' showing number of subjects, dosing of coadministered drug or grapefruit juice, dosing of lovastatin, and AUC ratio for lovastatin exposure. The table includes drugs such as Gemfibrozil, Itraconazole, Grapefruit Juice (high dose and low dose), Cyclosporine, and Diltiazem with various dosages and the corresponding effect on lovastatin exposure.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' comparing the proportion of participants without events over six years of follow-up between Lovastatin and placebo groups. The Lovastatin group shows a higher proportion without events, indicating a 37% risk reduction (p < 0.001) compared to placebo.*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Table VII Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as Strong CYP3A4 inhibitors, HIV protease inhibitors, and drugs like gemfibrozil, cyclosporine, danazol, diltiazem, and amiodarone. The table includes prescribing recommendations relevant to lovastatin use, such as contraindications and dosage limits.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.